Case number 1:17-cv-01039
Gilead Sciences, Inc. et al v. Macleods Pharmaceuticals, Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 8, 2020 | 1 | Complaint (46) |
| Dec 21, 2017 | 14 | Patent/Trademark Report to Commissioner (1) |
| Dec 21, 2017 | 14 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 6,642,245 B1; US 6,703,396 B1; US 8,592,397 B2; US 8,716,264 B2; US 9,457,036 B2. (Attachments: # (1) Notice of dismissal)(lih) |
| Dec 21, 2017 | 14 | Notice of dismissal (2) |
| Dec 21, 2017 | N/A | Terminated Case (0) Docket Text: CASE CLOSED (lih) |
| Dec 20, 2017 | 13 | Notice of Voluntary Dismissal (2) Docket Text: NOTICE of Voluntary Dismissal by Emory University, Gilead Sciences, Inc. (Farnan, Brian) |
| Dec 19, 2017 | N/A | SO ORDERED (0) Docket Text: SO ORDERED- re [12] STIPULATION TO EXTEND TIME. Set/Reset Answer Deadlines: Macleods Pharma USA, Inc. answer due 12/28/2017; Macleods Pharmaceuticals, Ltd. answer due 12/28/2017. Signed by Judge Sherry R. Fallon on 12/19/2017. (lih) |
| Dec 18, 2017 | 12 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to ANSWER Complaint to December 28, 2017 - filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals, Ltd.. (Stamoulis, Stamatios) |
| Nov 21, 2017 | N/A | SO ORDERED (0) |
| Nov 17, 2017 | 11 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to ANSWER Complaint to December 18, 2017 - filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals, Ltd.. (Stamoulis, Stamatios) |
| Nov 14, 2017 | N/A | SO ORDERED (0) |
| Nov 10, 2017 | 10 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to ANSWER Complaint to November 17, 2017 - filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals, Ltd.. (Stamoulis, Stamatios) |
| Oct 31, 2017 | N/A | SO ORDERED (0) |
| Oct 30, 2017 | 9 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Defendants to Respond to Complaint to November 10, 2017 - filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals, Ltd.. (Weinblatt, Richard) |
| Oct 11, 2017 | 8 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Gilead Sciences, Inc., Emory University. Macleods Pharma USA, Inc. served on 10/6/2017, answer due 10/27/2017. (Farnan, Brian) |
| Oct 6, 2017 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Christopher P. Borello,Frederick C. Millett for Emory University, Gilead Sciences, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb) |
| Oct 5, 2017 | 7 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Christopher Borello and Frederick Millett - filed by Emory University, Gilead Sciences, Inc.. Motions referred to Sherry R. Fallon.(Farnan, Brian) |
| Oct 5, 2017 | N/A | SO ORDERED (0) |
| Aug 2, 2017 | N/A | Case Referred to Magistrate Judge (0) Docket Text: CASE REFERRED to Magistrate Judge Sherry R. Fallon. (This matter has been assigned to the Vacant Judgeship and referred to a Magistrate Judge for handling through case-dispositive motions. The Magistrate Judge has full authority permitted by law to manage this matter, including entering schedules through trial, deciding non-dispositive matters and making recommendations as to the resolution of dispositive matters. Litigants and counsel are reminded that they have the option of consenting to the Magistrate Judge to handle the case in full, including trial, or consenting to having a particular motion resolved by the Magistrate Judge.) (rjb) |
| Aug 2, 2017 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Vacant Judgeship (2017). Please include initials of VAC after the case number on all documents filed. (rjb) |
| Jul 28, 2017 | 6 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Emory University. (Farnan, Brian) |
| Jul 28, 2017 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Gilead Sciences, Inc.. (Farnan, Brian) |
| Jul 27, 2017 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 6,642,245 B1; US 6,703,396 B1; US 8,592,397 B2; US 8,716,264 B2; US 9,457,036 B2. (nmg) |
| Jul 27, 2017 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 6/14/2017. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 12/14/2019. (nmg) |
| Jul 27, 2017 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) |
| Jul 27, 2017 | 1 | Civil Cover Sheet (1) |
| Jul 27, 2017 | 1 | Exhibit E (37) |
| Jul 27, 2017 | 1 | Exhibit D (29) |
| Jul 27, 2017 | 1 | Exhibit C (25) |
| Jul 27, 2017 | 1 | Exhibit B (19) |
| Jul 27, 2017 | 1 | Exhibit A (27) |
| Jul 27, 2017 | 1 | Main Document (46) Docket Text: COMPLAINT for PATENT INFRINGEMENT filed against Macleods Pharma USA, Inc., Macleods Pharmaceuticals, Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2191499.) - filed by Gilead Sciences, Inc., Emory University. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Civil Cover Sheet)(nmg) |
| Jul 27, 2017 | N/A | No Summons Issued (0) Docket Text: No Summons Issued. (nmg) |
